← All stocks

Corbus Pharmaceuticals Holdings, Inc.

CRBP Scheduled selling only

CIK 0001595097 #3966 in the set updated 17 Sep 2026

Bought (1 mo)

$0.00

out of their own pocket, the only kind of buying there is

Sold (1 mo)

$15.68K

$15.68K on a plan · $0.00 straight out of an exercise

Sold at will

$0.00

0 of 1 sales

Net

−$15.68K

$0.00 against sales at will

By person

14 insiders · 1 transaction

1.9×

Yuval Cohen holds only 1.9 times base salary in stock. $1.23M of shares against $646.57K in salary for 2025.

Salary from the company's own proxy. The shares are what Yuval Cohen last reported holding, valued at $7.84, the price Common Stock, par value $0.0001 per share was last bought or sold at on the open market here, on 14 Sep 2026.

Insider

Role

Bought

Sold

Net

Holding

Of company

Worth

Change

Ben Yong

Director

—

$15.68K (1) scheduled

−$15.68K

9,383

0.0485%

$73.58K

+237.2%

Cormorant Asset Management, LP entity

10% owner

—

2,344,971

12.12%

$18.39M

+15.8%

Cohen Yuval

Chief Executive Officer

—

157,316

0.8134%

$1.23M

+103.7%

Smethurst Dominic

Chief Medical Officer

—

89,790

0.4642%

$704.09K

+79.6%

Moran Sean F.

Chief Financial Officer

—

84,694

0.4379%

$664.13K

+74.2%

Saxena Nishant C

Chief Business Officer

—

77,900

0.4028%

$610.85K

+2,126%

Nicacio Leonardo Viana

Chief Medical Officer

—

58,333

0.3016%

$457.42K

—

Hodgson Ian

Chief Operating Officer

—

51,080

0.2641%

$400.54K

+96.6%

Kung Winston

Director

—

12,140

0.0628%

$95.20K

+118.1%

Jacques Rachelle Suzanne

Director

—

11,383

0.0589%

$89.26K

+309.0%

HOLMER ALAN F

Director

—

10,629

0.0550%

$83.35K

+82.3%

Altmeyer Anne

Director

—

7,579

0.0392%

$59.43K

+172.3%

Pfeiffenberger Brent

Director

—

7,500

0.0388%

$58.81K

—

Jenkins John Kenneth

Director

—

3,833

0.0198%

$30.06K

+36.1%

Corbus Pharmaceuticals Holdings, Inc.

By person

Individual transactions

What was left out